Mayo Clinic Cancer Center Rochester, Minnesota
Mayo Clinic Cancer Center is an NCI-designated Comprehensive Cancer Center. It was one of the first cancer centers to receive the NCI designation in 1971. In addition to the main campus in Minnesota, there are Mayo campuses in Jacksonville, Florida and Phoenix, Arizona.
Mayo’s 450 physicians and scientists collaborate across the spectrum of cancer research – including basic, translational, clinical and population sciences – seeking to find ways to lessen the burden of cancer. Mayo’s philosophy of patient care is that medicine is best practiced as a cooperative science with clinicians, specialists, and researchers working as a team. The 20,000 new patients seen at Mayo every year receive coordinated care from experts in all medical disciplines.
Mayo has formed collaborative teams across the three campuses, dedicated to: understanding the biology of cancer; discovering new ways to predict, prevent, diagnose, and treat cancer; and transforming the quality of life for cancer patients today and in the future. Mayo emphasizes the translation of knowledge gained from cancer research into effective therapies for patients.
The Mayo Cancer Center has 11 major cancer research programs: cell biology, immunology and immunotherapy, developmental therapeutics, gene and virus therapy, hematologic malignancies, neuro-oncology, prostate cancer, women’s cancer, gastrointestinal cancer, genetic epidemiology and risk assessment, and cancer prevention and control.
Mayo’s emphasis on collaboration has led to as many as 100 partnerships in recent years with scientists at institutions across the country, including investigators at NCI and at two dozen NCI-designated cancer centers. Mayo also maintains close partnerships with the Translational Genomics Research Institute (TGen) in Phoenix and the University of Minnesota.
There are approximately 900 cancer-related clinical trials available at Mayo, including studies administered through the Mayo-based North Central Cancer Treatment Group (NCCTG), as well as the newly formed Alliance for Clinical Trials in Oncology cooperative group, comprised of NCCTG, the American College of Surgeons Oncology Group, and Cancer and Leukemia Group B (CALGB).
These cooperative groups enable Mayo to recruit patients to clinical trials being conducted across the world. Their researchers are also committed to better understand and address health disparities. To that end, Mayo has developed relationships with underserved populations, including American Indians, Alaska Natives, African Americans, and Hispanics.
Mayo also focuses on comprehensive education and support for cancer patients and their caregivers. Its cancer education resource center serves nearly 35,000 visitors annually.
* This profile was provided by the Mayo Clinic Cancer Center.